Can I read Biosimilar Clinical Development: Scientific Considerations And New Methodologies (chapman & Hall/crc Biostatistics Series) on EtoBox?

Biosimilar Clinical Development: Scientific Considerations And New Methodologies (chapman & Hall/crc Biostatistics Series) by Kerry B. Barker, Sandeep M. Menon, Ralph B. D'Agostino Sr., Siyan Xu, Bo Jin PhD is a nonfiction available to read on EtoBox.

What is Biosimilar Clinical Development: Scientific Considerations And New Methodologies (chapman & Hall/crc Biostatistics Series) about?

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.

Who reads Biosimilar Clinical Development: Scientific Considerations And New Methodologies (chapman & Hall/crc Biostatistics Series)?

Author

Kerry B. Barker, Sandeep M. Menon, Ralph B. D'Agostino Sr., Siyan Xu, Bo Jin PhD

Publisher

Taylor & Francis Group; Chapman and Hall/CRC; CRC Press

Published

2017

Language

EN

ISBN

9781315373263

Category

nonfiction

Subjects

Medical, Mathematics, Science